Physician profile
Christopher Rizik
NPI 1104236058
$1,034.32
in general payments reported to CMS, 2019-2025
18 companies · $45.90 in 2025
The $45.90 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $654 · 2020: $157 · 2021: $19.64 · 2022: $20.03 · 2023: $41.84 · 2024: $95.10 · 2025: $45.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $182.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $176.35 | 2019-2022 | |
| Abbvie INC. | $149.20 | 2023-2025 | Botox |
| Boston Scientific Corporation | $97.57 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $87.41 | 2019 | |
| Merz North America, INC. | $71.83 | 2019 | |
| Vertiflex, INC. | $69.88 | 2019 | |
| Vertical Pharmaceuticals, LLC | $69.66 | 2019 | |
| Collegium Pharmaceutical, INC. | $64.97 | 2019 | |
| Nevro Corp. | $41.13 | 2019 | |
| Amgen INC. | $36.93 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.16 | 2019 | |
| Medtronic, INC. | $33.64 | 2024 | Synchromedii |
| Sanofi-Aventis U.S. LLC | $26.13 | 2019 | |
| Pfizer INC. | $25.37 | 2019 | |
| Abbott Laboratories | $13.10 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pernix Therapeutics Holdings, INC. | $12.64 | 2019 | |
| Fidia Pharma USA INC. | $12.15 | 2019 | |
| Kaleo, INC. | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Rizik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.